Sanofi Prevails in Colo. Federal Taxotere Hair Loss Case
April 11, 2024
DOCUMENTS
- Order
- Order
BOULDER, Colo. — A Colorado federal judge has awarded Sanofi-Aventis summary judgment in a Taxotere (docetaxel) case, ruling the claims are time-barred because the plaintiff knew or should have known by 2009 that the chemotherapy drug caused her permanent hair loss.
In an April 9 order, Judge Charlotte N. Sweeney of the U.S. District Court for the District of Colorado further found that amendment of the complaint would be futile because the plaintiff’s deposition testimony and the entire record demonstrate that her claims began to accrue by 2009 at the latest.
Colorado resident Gina McClaflin was administered Taxotere from …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick